Kolexia
Saada Veronique
Pharmacien
Gustave-Roussy
Villejuif, France
1 K Activités
2 K Followers

Scientifique
Digital
Production scientifique
Activités par an
Expertise
Sujets de recherche
{{person.topmesh1.name}} Leucémies Leucémie aigüe myéloïde Leucémie myéloïde Syndromes myélodysplasiques COVID-19 Leucémie myélomonocytaire chronique Sarcomes Myélome multiple Seconde tumeur primitive

Industries

Janssen
3 collaboration(s)
Dernière en 2022
B3TSI
2 collaboration(s)
Dernière en 2022
Celgene
1 collaboration(s)
Dernière en 2020
Sysmex
1 collaboration(s)
Dernière en 2022

Dernières activités

Sensitivity, specificity, and accuracy of molecular profiling on circulating cell-free DNA in refractory or relapsed multiple myeloma patients, results of MM-EP1 study.
Leukemia & lymphoma   03 mars 2024
1-Year Data Analysis from a Cancer Center Molecular Tumor Board Dedicated to Clonal Hematopoiesis
65th ASH Annual Meeting Abstracts   02 novembre 2023
The purinergic receptor P2X7 and the NLRP3 inflammasome are druggable host factors required for SARS-CoV-2 infection.
Frontiers in immunology   18 octobre 2023
An atypical promyelocytic sarcoma and pleural effusion in a patient with Gorham's disease: Efficiency of ATRA/ATO-based treatment.
Clinical case reports   16 août 2023
Raising concerns on questionable ethics approvals - a case study of 456 trials from the Institut Hospitalo-Universitaire Méditerranée Infection.
Research integrity and peer review   03 août 2023
Letter to Editor "Innate immune suppression by SARS-CoV-2 mRNA vaccinations: The role of G-quadruplexes, exosomes, and MicroRNAs": Important concerns on the validity of this article.
Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association   14 juin 2023
When monoclonal gammopathy-associated chronic neutrophilic leukemia is a reactive process distinct from a clonal myeloproliferative neoplasm: Lessons from mistakes.
EJHaem   19 mai 2023
Myelodysplastic syndrome following chimeric antigen receptor T-cell therapy treated with allogenic stem cell transplantation.
Immunotherapy   23 mars 2023
Reduced Venetoclax Exposition to Seven Days of Azacitidine Is Efficient in Treatment-Naïve Patients with Acute Myeloid Leukemia
Annual Meeting Abstracts 2022   15 novembre 2022
AML MRD By Multiparameter Flow Cytometry Using Laip/Dfn and LSC: Methodological Aspects in a Multicentric Study of the French-Flow MRD AML ALFA Network
Annual Meeting Abstracts 2022   15 novembre 2022